JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 26:1251-1256
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koifman, B
Right arrow Articles by Iaina, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koifman, B
Right arrow Articles by Iaina, A

Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure

B Koifman, Y Wollman, N Bogomolny, T Chernichowsky, A Finkelstein, G Peer, J Scherez, M Blum, S Laniado, A Iaina, et al.

Department of Cardiology, Tel Aviv Medical Center, Tel Aviv University, Israel.

OBJECTIVES. The aim of this study was to evaluate the hemodynamic effect of L-arginine infusion in patients with congestive heart failure. BACKGROUND. Endothelium-dependent vasodilation is impaired in patients with congestive heart failure. Nitric oxide, which was identified as endothelium-derived relaxing factor, is generated by nitric oxide synthase from L-arginine. Our hypothesis was that administration of L-arginine in patients with congestive heart failure may increase nitric oxide production and have a beneficial hemodynamic effect. METHODS. Twelve patients with congestive heart failure (New York Heart Association class II or III) due to coronary artery disease (left ventricular ejection fraction < 35%) were given 20 g of L-arginine by intravenous infusion over 1 h at a constant rate. Stroke volume, cardiac output and left ventricular ejection fraction were determined with Doppler echocardiography at baseline and at 30 and 60 min and 1 h after the end of infusion. Blood and urinary levels of nitrite/nitrate (NO2/NO3), stable metabolites of nitric oxide, were measured and clearance was calculated. RESULTS. One hour of infusion of L-arginine resulted in a significant increase in stroke volume (from 68 +/- 18 ml to 76 +/- 23 ml [mean +/- SD], p = 0.014) and cardiac output (from 4.07 +/- 1.22 liters/min to 4.7 +/- 1.42 liters/min, p = 0.006) without a change in heart rate. Mean arterial blood pressure decreased (from 102 +/- 11 mm Hg to 89 +/- 9.5 mm Hg, p < 0.002), and systemic vascular resistance decreased significantly. Within 1 h after cessation of L-arginine infusion, blood pressure, stroke volume, cardiac output and systemic vascular resistance were statistically not different from baseline values. Clearance of NO2/NO3 increased significantly during L-arginine administration (from 13.28 +/- 0.42 ml/min to 29.97 +/- 1.09 ml/min, p < 0.001). CONCLUSIONS. Infusion of L-arginine in patients with congestive heart failure results in increased production of nitric oxide, peripheral vasodilation and increased cardiac output, suggesting a beneficial hemodynamic and possibly therapeutic profile.


This article has been cited by other articles:


Home page
J. Physiol.Home page
R. D. Peluffo
L-Arginine currents in rat cardiac ventricular myocytes
J. Physiol., May 1, 2007; 580(3): 925 - 936.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. V. Remillard and J. X.-J. Yuan
Cardiac L-arginine transport: the CAT is back
J. Physiol., May 1, 2007; 580(3): 699 - 700.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. NAGAYA, M. UEMATSU, H. OYA, N. SATO, F. SAKAMAKI, S. KYOTANI, K. UENO, N. NAKANISHI, M. YAMAGISHI, and K. MIYATAKE
Short-term Oral Administration of L-Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 887 - 891.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
A.C. Mendes Ribeiro, T.M.C. Brunini, J.C. Ellory, and G.E. Mann
Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure
Cardiovasc Res, March 1, 2001; 49(4): 697 - 712.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Greenberg, G. Chemin, I. Shapira, J. George, Y. Wollman, S. Laniado, and G. Keren
Captopril and L-Arginine Have a Synergistic Cardioprotective Effect in Ischemic-Reperfusion Injury in the Isolated Rat Heart
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 281 - 290.
[Abstract] [PDF]


Home page
HeartHome page
Y Kanaya, M Nakamura, N Kobayashi, and K Hiramori
Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure
Heart, May 1, 1999; 81(5): 512 - 517.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Dakak, S. Husain, D. Mulcahy, N. P. Andrews, J. A. Panza, M. Waclawiw, W. Schenke, and A. A. Quyyumi
Contribution of Nitric Oxide to Reactive Hyperemia : Impact of Endothelial Dysfunction
Hypertension, July 1, 1998; 32(1): 9 - 15.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
L-Arginine Improves Cardiac Performance in CHF
Journal Watch Cardiology, January 1, 1996; 1996(101): 9 - 9.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.